Danaher Stock Is Down 19% In the Past 3 Months. Could DHR Reach $248?

Danaher (DHR) stock has seen a 19% decline in the past three months, but its recent Q1 2026 earnings report showed signs of recovery with a 3.5% revenue increase and raised full-year EPS guidance. A valuation model, assuming moderate growth, strong margins, and a normalized P/E, projects DHR could reach $248 per share by late 2028, representing a 27% total return from its current price of $195. Key factors include improving bioprocessing demand, the integration of the Masimo acquisition, and consistent cash generation.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin